Microencapsulation Unlocks Stability and Commercial Viability of Akkermansia muciniphila

One of the key challenges in commercializing Akkermansia muciniphila as a next-generation probiotic is its extreme sensitivity to oxygen, moisture, and temperature, which significantly compromises viability during processing and shelf life. Microencapsulation technology addresses this by forming a protective barrier around the bacteria, limiting oxygen exposure, reducing moisture ingress, and enhancing thermal stability during manufacturing processes like spray drying. As a result, microencapsulation not only improves storage stability but also enhances survivability of Akkermansia in complex formulations and delivery formats, increasing its potential for effective gut delivery. This approach is critical for enabling scalable, consumer-ready probiotic products while maintaining the functional integrity of this highly oxygen-sensitive strain.

Source : https://www.nutraingredients.com/News/Promotional-features/microencapsulation-technology-for-akkermansia-muciniphila-stability/